|
 |
 |
11/19/2008
Patients Experienced Nearly A 70% Reduction In Pain When Using MPM Medical's Regenecare Wound Care Gel
A recent clinical study found that patients experienced nearly a 70% reduction in pain when MPM Medical Inc.'s Regenecare HA® hydrogel was used prior to and during the changing of their wound dressings. The finding comes at a time when a cross-section of American thought leaders are calling the lack of proper pain management a national healthcare crisis. In answer, members of Congress have united to sponsor the National Pain Care Policy Act of 2008 (H.R.
more info
|
11/19/2008
Metastatic Melanoma - Provectus Adds 6th Center To Phase 2 Clinical Trial Of PV-10
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, has begun recruitment for its Phase 2 clinical trial of the Company's lead oncology agent PV-10 at a sixth major center located at the California Pacific Medical Center, in San Francisco, CA. David Minor, M.D. will serve as principal investigator at the new center covering the western United States.
more info
|
11/19/2008
Michelson Diagnostics To Demonstrate Prototype Hand-Held OCT Probe At BIOS 09
Michelson Diagnostics has announced that it will demonstrate its prototype multi-beam Optical Coherence Tomography (OCT) probe at the BIOS Exhibition at SPIE Photonics West, San Jose, 24-25th January 2009 (Stand 8731). More than one variant of the new probe will be launched later in 2009, including a dermal version (with X-Y scanning, to enable 3D mapping of skin lesions) and a version equipped with a rigid endoscope, suitable for oral applications.
more info
|
11/19/2008
Australia/New Zealand Join Forces On New Treatment Guidelines For Melanoma
In a cross-Tasman first, Australia and New Zealand have collaborated with a joint approach to the development of treatment guidelines for cancer, to be launched today (19/11) at the Clinical Oncological Society of Australia Annual Scientific Meeting in Sydney.
more info
|
11/19/2008
Vitamin Boosts Immunity Against Skin Cancer
Nicotinamide (VitB3), a vitamin found in common foods like meats, nuts, grains and cereals, may provide the next advance in skin cancer prevention, according to new research from the University of Sydney. Presenting the results of a trial to the Clinical Oncological Society of Australia's Annual Scientific Meeting today (19 Nov), Associate Professor Diona Damian said tests had shown the vitamin prevented damage from ultraviolet (UV) radiation by protecting the immune system.
more info
|
|
 |
|
